data13F

RGNX – Regenxbio Inc

Held by 1 of 60 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding1
Combined shares30,248
Combined reported value$228K

RGNX chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Paul Tudor Jones narrow view 0.00 Added 26.8%30,248$228KQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Added 26.8%30,2480.00
Q2 2026Paul Tudor Jones narrow view Reduced 1.9%23,8540.00
Q4 2025Paul Tudor Jones narrow view New24,3100.00

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Added 26.8%30,2480.00
Q4 2025Paul Tudor Jones narrow view New24,3100.00

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Paul Tudor Jones narrow view Reduced 1.9%23,8540.00

History

1 peakQ3 2026: 1 tracked investors
Q3 2015: 1 tracked investorsQ1 2017: 1 tracked investorsQ1 2021: 1 tracked investorsQ1 2022: 1 tracked investorsQ3 2022: 1 tracked investorsQ4 2022: 1 tracked investorsQ1 2023: 1 tracked investorsQ2 2023: 1 tracked investorsQ3 2023: 1 tracked investorsQ2 2024: 1 tracked investorsQ3 2024: 1 tracked investorsQ1 2025: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20152026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Paul Tudor Jones30.2K23.9K24.3K24.3K––24.1K–

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).